123 related articles for article (PubMed ID: 8349309)
1. Production of a monoclonal antibody inhibiting the killer activity.
Suzuki Y; Funabashi M; Suzuki R; Notake K; Yokochi T
Immunol Lett; 1993 May; 36(2):125-9. PubMed ID: 8349309
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of a novel monoclonal antibody inhibitory for murine natural killer cell activity.
Hoskin DW; Roder JC
Immunol Invest; 1992 Feb; 21(1):11-23. PubMed ID: 1548044
[TBL] [Abstract][Full Text] [Related]
3. Preparation of monoclonal antibodies against a glycolipid asialo GM1.
Shimada S; Iwata D
Microbiol Immunol; 1987; 31(9):923-33. PubMed ID: 3696009
[TBL] [Abstract][Full Text] [Related]
4. A phenyl-beta-galactoside-specific monoclonal antibody reactive with murine and rat NK cells.
Miller VE; Lagarde AE; Longenecker BM; Greenberg AH
J Immunol; 1986 Apr; 136(8):2968-74. PubMed ID: 2420880
[TBL] [Abstract][Full Text] [Related]
5. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1987 Sep; 108(2):313-22. PubMed ID: 3113742
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody with reactivity to asialo GM1 and murine natural killer cells.
Solomon FR; Higgins TJ
Mol Immunol; 1987 Jan; 24(1):57-65. PubMed ID: 3614206
[TBL] [Abstract][Full Text] [Related]
9. Two natural killer cell populations which belong to T cell lineage in nude mice.
Habu S; Shimamura K; Tamaoki N; Kumagai Y; Okumura K
Eur J Immunol; 1986 Nov; 16(11):1453-6. PubMed ID: 2877886
[TBL] [Abstract][Full Text] [Related]
10. LGL-1: a non-polymorphic antigen expressed on a major population of mouse natural killer cells.
Mason L; Giardina SL; Hecht T; Ortaldo J; Mathieson BJ
J Immunol; 1988 Jun; 140(12):4403-12. PubMed ID: 2453582
[TBL] [Abstract][Full Text] [Related]
11. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody (RH1-38) which inhibits multiple systems of cell-mediated cytotoxicity--I. Identification of a novel epitope on a killer cell surface bimolecular complex important in the cytotoxic response.
Hall RE
Mol Immunol; 1985 Jul; 22(7):757-64. PubMed ID: 2412110
[TBL] [Abstract][Full Text] [Related]
14. Establishment of hybridoma cells with natural killer(NK)-like activity against syngenic tumor cells.
Suzuki Y; Funabashi M; Isomura S; Yoshikawa K; Notake K; Yokochi T
Microbiol Immunol; 1992; 36(4):401-6. PubMed ID: 1406367
[TBL] [Abstract][Full Text] [Related]
15. Identification of murine natural killer cell subsets with monoclonal antibodies derived from 129 anti-C57BL/6 immune spleen cells.
Lemieux S; Ouellet-Talbot F; Lusignan Y; Morelli L; Labrèche N; Gosselin P; Lecomte J
Cell Immunol; 1991 Apr; 134(1):191-204. PubMed ID: 2013102
[TBL] [Abstract][Full Text] [Related]
16. Characterization of effector cells against B16 melanoma in mice inoculated with allogeneic spleen cells.
Nishi Y; Hosokawa T; Aoike A; Han D; Takehara H; Kawai K; Kamahora T
Microbiol Immunol; 1994; 38(3):217-23. PubMed ID: 7915815
[TBL] [Abstract][Full Text] [Related]
17. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
[TBL] [Abstract][Full Text] [Related]
18. A killer cell protective antigen expressed by MHC-unrestricted killer hybridomas.
Kubota K
Cell Immunol; 1997 Oct; 181(1):50-8. PubMed ID: 9344496
[TBL] [Abstract][Full Text] [Related]
19. Characterization of four new monoclonal antibodies that recognize mouse natural killer activation receptors.
Kung SK; Su RC; Shannon J; Miller RG
Hybridoma; 2001 Apr; 20(2):91-101. PubMed ID: 11394535
[TBL] [Abstract][Full Text] [Related]
20. Eradication of established human melanoma tumors in nude mice by antibody-directed effector cells.
Schulz G; Staffileno LK; Reisfeld RA; Dennert G
J Exp Med; 1985 Jun; 161(6):1315-25. PubMed ID: 4009116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
